Correlation Between Akero Therapeutics and Taysha Gene
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Taysha Gene Therapies, you can compare the effects of market volatilities on Akero Therapeutics and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Taysha Gene.
Diversification Opportunities for Akero Therapeutics and Taysha Gene
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Akero and Taysha is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Taysha Gene go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Taysha Gene
Given the investment horizon of 90 days Akero Therapeutics is expected to under-perform the Taysha Gene. But the stock apears to be less risky and, when comparing its historical volatility, Akero Therapeutics is 2.5 times less risky than Taysha Gene. The stock trades about -0.06 of its potential returns per unit of risk. The Taysha Gene Therapies is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Taysha Gene Therapies on October 26, 2024 and sell it today you would lose (44.00) from holding Taysha Gene Therapies or give up 22.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Taysha Gene Therapies
Performance |
| Timeline |
| Akero Therapeutics |
| Taysha Gene Therapies |
Akero Therapeutics and Taysha Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Taysha Gene
The main advantage of trading using opposite Akero Therapeutics and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Taysha Gene vs. Biomea Fusion | Taysha Gene vs. Stoke Therapeutics | Taysha Gene vs. Akero Therapeutics | Taysha Gene vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |